Fahad Nadeem Khan
Novo Nordisk
Global Commercial Director
The go to market model of the future
- Adapting to the changing dynamics and customer needs.
- Invest in digital mindset and capabilities
- Enhance the overall experience
Maria Nieves Alvarado
Astellas Pharma
Associate Director, Global HCP Portal Lead
Latest digital trends shaping pharma marketing into first-class HCP, patient and stakeholder approaches.
Rodolphe Janssens
Gilead Sciences
Director Commercial Operations BeLux
The voice of Local in the omnichannel transformation
- Infrastructure transformation
- What about People transformation?
- SFE and Digital transformation: the lever you need
- Global with Local
Andrew Binns
AstraZeneca
Head of Digital & Innovation
The Power of Empathy and Creativity to drive excellence in customer engagement
- Understanding - how to gain deep insights into who the target audiences are and how to engage them
- Impacting - using contextual content and empathetic messaging to grab attention and activate the target audiences
- Reporting - developing hard KPIs to understand the impact the campaign has made
Catarina Santos
Novartis
Executive Director
Achieving the best launch outputs with an integrated x-functional digital launch plan (Medical, Access and Marketing)
Pablo Moreno
IPSEN
Strategic Business Excellence Director Iberia
The Salesforce of the Future
- Relational vs. Scientific approach.
- Digital commercial strategies. How to master the promotional mix.
- Deep knowledge of the customers and potential biases.
- Implementation within a salesforce of the present. Barriers & quick wins.
The most profitable business owners and leaders know that business transformation, commercial excellence, and digital strategy are never-ending processes. Putting the consumer first is only possible if you have connectivity and creative solutions to optimize the data at your disposal. If these macroeconomic forces move upward, investing in your commercial talents will add value and set your organization apart, especially since many markets are experiencing economic and commercial downturns. It is an outcome-driven strategy that draws on proven solutions taken from the most successful clientele. Compared to traditional transformation programs, it is built around a succession of trials for maximum flexibility, minimal risk, and the capacity to quickly scale up patient-centric design for your digital engagement and integrate the most recent technological advancements, such as AI and cloud systems, and real-time action data into the pharmaceutical marketing model to make strategic digital decisions that reshape and improve the experience for everyone from patients to transactional users.